Serina Therapeutics

Serina Therapeutics, Inc. was founded in 2006 by Drs. Milton Harris and Michael Bentley who developed and patented much of the polymer technology known as PEG, or PEGylation, during their work at Shearwater Polymers and Nektar Therapeutics. PEG became widely accepted as the polymer standard for drug development. Today, greater than $120 B of cumulative product sales can be attributed to this technology.